Technology ID
TAB-4555

Engineered Human Induced Pluripotent Stell Cell (iPSC) Lines for Multiple Therapeutic and Diagnostic Uses

E-Numbers
E-091-2012-0
Lead Inventor
Rao, Mahendra (New York Stem Cell Foundation)
Applications
Therapeutics
Research Materials
Diagnostics
Development Stages
Pre-Clinical (in vitro)
Research Products
Human iPSC Lines
Lead IC
NIAMS

This technology includes ten engineered human induced pluripotent stem cell (iPSC) lines with reported genes inserted into safe harbor sites for use in therapy and diagnostic screening assay development as well as basic stem cell biology research. These cell lines have the potential to differentiate into all cells in the body, and theoretically can proliferate/self-renew indefinitely.

Commercial Applications
Utilized in studies that could facilitate the development of cellular therapies, more effective drug treatments through their use as screening assays, and improved understanding of basic stem cell biology.

Competitive Advantages
The pluripotent nature of these cell lines gives them the potential to differentiate into all cells in the body, and proliferate indefinitely, giving them a wide range of uses.

Request More Info

Licensing Contact:
Knezevic, Vladimir
vlado.knezevic@nih.gov

Collaborations

  • Licensing

Collaboration Description

  • We are seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize this technology.
Date Published